SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-23-000018
Filing Date
2023-07-28
Accepted
2023-07-28 07:00:01
Documents
120
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K sny-20230630.htm   iXBRL 6-K 443331
2 EX-99.1 sny-20230630_d2.htm   iXBRL EX-99.1 1676203
3 EX-99.2 exhibit992-2023halfyearman.htm EX-99.2 731754
10 a1a.gif GRAPHIC 86565
11 a2a.gif GRAPHIC 107127
12 a3a.gif GRAPHIC 83254
13 backcoverrapportsemestriela.jpg GRAPHIC 955456
14 coverrapportsemestrielenrgb.jpg GRAPHIC 8266878
  Complete submission text file 0001121404-23-000018.txt   26788651

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sny-20230630.xsd EX-101.SCH 146552
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sny-20230630_cal.xml EX-101.CAL 131702
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sny-20230630_def.xml EX-101.DEF 523028
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sny-20230630_lab.xml EX-101.LAB 1085019
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sny-20230630_pre.xml EX-101.PRE 720027
115 EXTRACTED XBRL INSTANCE DOCUMENT sny-20230630_htm.xml XML 2696044
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231120171
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences